Skip to main content
. 2019 Dec;8(6):683–690. doi: 10.21037/gs.2019.11.07

Table 1. Clinicopathological features and survival.

Patient Gender Age (years) Primary symptom T (cm) Stage (TNM) Histological grade Treatment strategy Treatment response Survival (months)
1 Female 65 Neck pain 3.1 IVc Moderate C NR 5.5
2 Female 57 Hoarseness 4.1 IVc High-moderate R NR 6.5
3 Female 60 Neck mass 3.2 IVb Moderate R + C PD 9
4 Male 79 Neck mass 5.0 IVb High R + C NR 4.5
5 Male 61 Hoarseness 2.8 IVb Moderate-low S + R PR 11.5
6 Male 38 Dyspnea 5.5 IVc High R NR 2
7 Male 62 No 2.3 IVa Low S + R + C PR 14
8 Male 59 Neck mass 3.3 IVa Low S + R + C PR 13
9 Male 43 Dysphagia 4.5 IVb Low S + R PD 10
10 Male 41 Neck mass 3.5 IVa Low S + R PR 12.5
11 Male 42 Neck mass 4.2 IVb Moderate-low R + C PR 11.5
12 Male 48 No 1.8 IVa Low S + R SD 18

C, chemotherapy; R, radiotherapy; S, surgery; NR, no response; PR, partial response; PD, progressive disease; SD, stable disease.